The global DPT Vaccines market size was valued at US$ 5541 million in 2024 and is forecast to a readjusted size of USD 6992 million by 2031 with a CAGR of 3.4% during review period.
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report is a detailed and comprehensive analysis for global DPT Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Age. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global DPT Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2020-2031
Global DPT Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2020-2031
Global DPT Vaccines market size and forecasts, by Type and by Age, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (US$/Dose), 2020-2031
Global DPT Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (US$/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DPT Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DPT Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
DPT Vaccines market is split by Type and by Age. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Age in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
DTaP
Tdap
DTwP
麻豆原创 segment by Age
12 Months Below
12 Months Above
Major players covered
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DPT Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DPT Vaccines, with price, sales quantity, revenue, and global market share of DPT Vaccines from 2020 to 2025.
Chapter 3, the DPT Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DPT Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Age, with sales market share and growth rate by Type, by Age, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and DPT Vaccines market forecast, by regions, by Type, and by Age, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Vaccines.
Chapter 14 and 15, to describe DPT Vaccines sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global DPT Vaccines Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 DTaP
1.3.3 Tdap
1.3.4 DTwP
1.4 麻豆原创 Analysis by Age
1.4.1 Overview: Global DPT Vaccines Consumption Value by Age: 2020 Versus 2024 Versus 2031
1.4.2 12 Months Below
1.4.3 12 Months Above
1.5 Global DPT Vaccines 麻豆原创 Size & Forecast
1.5.1 Global DPT Vaccines Consumption Value (2020 & 2024 & 2031)
1.5.2 Global DPT Vaccines Sales Quantity (2020-2031)
1.5.3 Global DPT Vaccines Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Sanofi Pasteur
2.1.1 Sanofi Pasteur Details
2.1.2 Sanofi Pasteur Major Business
2.1.3 Sanofi Pasteur DPT Vaccines Product and Services
2.1.4 Sanofi Pasteur DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Sanofi Pasteur Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK DPT Vaccines Product and Services
2.2.4 GSK DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 GSK Recent Developments/Updates
2.3 Mitsubishi Tanabe Pharma
2.3.1 Mitsubishi Tanabe Pharma Details
2.3.2 Mitsubishi Tanabe Pharma Major Business
2.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Product and Services
2.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.4 KM Biologics
2.4.1 KM Biologics Details
2.4.2 KM Biologics Major Business
2.4.3 KM Biologics DPT Vaccines Product and Services
2.4.4 KM Biologics DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 KM Biologics Recent Developments/Updates
2.5 Wuhan Institute of Biological Products
2.5.1 Wuhan Institute of Biological Products Details
2.5.2 Wuhan Institute of Biological Products Major Business
2.5.3 Wuhan Institute of Biological Products DPT Vaccines Product and Services
2.5.4 Wuhan Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
2.6 Walvax Biotechnology
2.6.1 Walvax Biotechnology Details
2.6.2 Walvax Biotechnology Major Business
2.6.3 Walvax Biotechnology DPT Vaccines Product and Services
2.6.4 Walvax Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Walvax Biotechnology Recent Developments/Updates
2.7 Chengdu Institute of Biological Products
2.7.1 Chengdu Institute of Biological Products Details
2.7.2 Chengdu Institute of Biological Products Major Business
2.7.3 Chengdu Institute of Biological Products DPT Vaccines Product and Services
2.7.4 Chengdu Institute of Biological Products DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
2.8 Minhai Biotechnology
2.8.1 Minhai Biotechnology Details
2.8.2 Minhai Biotechnology Major Business
2.8.3 Minhai Biotechnology DPT Vaccines Product and Services
2.8.4 Minhai Biotechnology DPT Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Minhai Biotechnology Recent Developments/Updates
3 Competitive Environment: DPT Vaccines by Manufacturer
3.1 Global DPT Vaccines Sales Quantity by Manufacturer (2020-2025)
3.2 Global DPT Vaccines Revenue by Manufacturer (2020-2025)
3.3 Global DPT Vaccines Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of DPT Vaccines by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 DPT Vaccines Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 DPT Vaccines Manufacturer 麻豆原创 Share in 2024
3.5 DPT Vaccines 麻豆原创: Overall Company Footprint Analysis
3.5.1 DPT Vaccines 麻豆原创: Region Footprint
3.5.2 DPT Vaccines 麻豆原创: Company Product Type Footprint
3.5.3 DPT Vaccines 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global DPT Vaccines 麻豆原创 Size by Region
4.1.1 Global DPT Vaccines Sales Quantity by Region (2020-2031)
4.1.2 Global DPT Vaccines Consumption Value by Region (2020-2031)
4.1.3 Global DPT Vaccines Average Price by Region (2020-2031)
4.2 North America DPT Vaccines Consumption Value (2020-2031)
4.3 Europe DPT Vaccines Consumption Value (2020-2031)
4.4 Asia-Pacific DPT Vaccines Consumption Value (2020-2031)
4.5 South America DPT Vaccines Consumption Value (2020-2031)
4.6 Middle East & Africa DPT Vaccines Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global DPT Vaccines Sales Quantity by Type (2020-2031)
5.2 Global DPT Vaccines Consumption Value by Type (2020-2031)
5.3 Global DPT Vaccines Average Price by Type (2020-2031)
6 麻豆原创 Segment by Age
6.1 Global DPT Vaccines Sales Quantity by Age (2020-2031)
6.2 Global DPT Vaccines Consumption Value by Age (2020-2031)
6.3 Global DPT Vaccines Average Price by Age (2020-2031)
7 North America
7.1 North America DPT Vaccines Sales Quantity by Type (2020-2031)
7.2 North America DPT Vaccines Sales Quantity by Age (2020-2031)
7.3 North America DPT Vaccines 麻豆原创 Size by Country
7.3.1 North America DPT Vaccines Sales Quantity by Country (2020-2031)
7.3.2 North America DPT Vaccines Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe DPT Vaccines Sales Quantity by Type (2020-2031)
8.2 Europe DPT Vaccines Sales Quantity by Age (2020-2031)
8.3 Europe DPT Vaccines 麻豆原创 Size by Country
8.3.1 Europe DPT Vaccines Sales Quantity by Country (2020-2031)
8.3.2 Europe DPT Vaccines Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific DPT Vaccines Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific DPT Vaccines Sales Quantity by Age (2020-2031)
9.3 Asia-Pacific DPT Vaccines 麻豆原创 Size by Region
9.3.1 Asia-Pacific DPT Vaccines Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific DPT Vaccines Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America DPT Vaccines Sales Quantity by Type (2020-2031)
10.2 South America DPT Vaccines Sales Quantity by Age (2020-2031)
10.3 South America DPT Vaccines 麻豆原创 Size by Country
10.3.1 South America DPT Vaccines Sales Quantity by Country (2020-2031)
10.3.2 South America DPT Vaccines Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa DPT Vaccines Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa DPT Vaccines Sales Quantity by Age (2020-2031)
11.3 Middle East & Africa DPT Vaccines 麻豆原创 Size by Country
11.3.1 Middle East & Africa DPT Vaccines Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa DPT Vaccines Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 DPT Vaccines 麻豆原创 Drivers
12.2 DPT Vaccines 麻豆原创 Restraints
12.3 DPT Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of DPT Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of DPT Vaccines
13.3 DPT Vaccines Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DPT Vaccines Typical Distributors
14.3 DPT Vaccines Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
听
听
*If Applicable.
